Dr. David Joseph Iberri, MD

Dr. Iberri practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Iberri's NPI, 1821300625, was assigned on July 8, 2010. Dr. Iberri graduated from The Robert Larner, M.D. College of Medicine in 2010. Dr. Iberri holds California license A117947.

Dr. Iberri's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Iberri's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Iberri is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Iberri to 1 more hospital and 1 medical group, each named with a free account. Dr. Iberri's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iberri practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Iberri's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Iberri is board certified in hematology by the American Board of Internal Medicine. Dr. Iberri is licensed in California.

Dmand AI lists anemia, cellulitis, chronic anemia, congestive heart failure, deep vein thrombosis (DVT), gastrointestinal bleeding, gastrointestinal inflammation and heart valve disorders among the conditions Dr. Iberri treats.

CMS data shows 1,902 Medicare services from Dr. Iberri across 8 procedure codes in 2024, for 557 Medicare patients. Medicare paid $200,971 for them.

CMS counts 557 Medicare patients who saw Dr. Iberri in 2024. The largest group is 75 to 84, with 231 patients. 70% of them have high blood pressure, and 69% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iberri's median patient age at 68, with 46% women.

In 2024, Dr. Iberri wrote 199 Medicare Part D claims for 61 patients. 69% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $4,174 in total drug cost. In 2023, CMS named 54 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Iberri for performance year 2024, reported as part of a group. Dr. Iberri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iberri as offering telehealth.

Dmand AI links 18 papers to Dr. Iberri, published from 2011 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Multiple Myeloma, Adenine and Antineoplastic Agents. Dr. Iberri has published most often in Bone Marrow Transplant. Dr. Iberri's most frequent co-authors are Michaela Liedtke, MD, Sally Arai, MD and David Bernard Miklos, MD, PhD.

CMS Open Payments shows 1 general payment to Dr. Iberri from 1 drug or device company in 2016. Education make up the largest share, 100% of the total. Shire North American Group Inc paid the most, $87.

Dr. Iberri graduated from The Robert Larner, M.D. College of Medicine in 2010.

Dr. Iberri is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.